Recro Pharma Current Ratio 2014-2020 | REPH

Recro Pharma current ratio from 2014 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Recro Pharma Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-09-30 $0.06B $0.02B 3.95
2020-06-30 $0.06B $0.01B 4.45
2020-03-31 $0.06B $0.01B 6.14
2019-12-31 $0.06B $0.01B 9.28
2019-09-30 $0.08B $0.01B 8.07
2019-06-30 $0.07B $0.01B 8.66
2019-03-31 $0.10B $0.03B 3.57
2018-12-31 $0.07B $0.03B 2.45
2018-09-30 $0.07B $0.05B 1.36
2018-06-30 $0.08B $0.05B 1.59
2018-03-31 $0.08B $0.05B 1.78
2017-12-31 $0.09B $0.05B 1.75
2017-09-30 $0.07B $0.04B 1.59
2017-06-30 $0.07B $0.01B 5.80
2017-03-31 $0.08B $0.01B 5.97
2016-12-31 $0.09B $0.02B 5.21
2016-09-30 $0.05B $0.01B 4.35
2016-06-30 $0.04B $0.01B 2.85
2016-03-31 $0.04B $0.01B 2.91
2015-12-31 $0.04B $0.01B 4.08
2015-09-30 $0.05B $0.02B 2.53
2015-06-30 $0.04B $0.02B 2.69
2015-03-31 $0.02B $0.00B 6.69
2014-12-31 $0.02B $0.00B 14.09
2014-09-30 $0.02B $0.00B 12.58
2014-06-30 $0.03B $0.00B 21.01
2014-03-31 $0.03B $0.00B 36.65
2013-12-31 $0.00B $0.01B 0.07
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.072B $0.099B
Recro Pharma, Inc. is a clinical stage specialty pharmaceutical company. It develops non-opioid therapeutics for the treatment of pain in the post-operative setting. The company is developing intranasal formulation of Dexmedetomidine (Dex) for the treatment of post-operative pain and cancer breakthrough pain; sublingual formulation of Dex for the treatment of chronic pain; and Fadolmidine (Fado), a product candidate to treat post-operative pain and neuropathic pain. Recro Pharma, Inc. is based in Malvern, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.264B 42.12
Takeda Pharmaceutical (TAK) Japan $54.984B 10.26
Astellas Pharma (ALPMY) Japan $29.696B 18.55
Merck (MKGAF) Germany $23.264B 0.00
Eisai (ESALY) Japan $21.993B 19.16
UCB SA (UCBJF) Belgium $20.900B 0.00
Catalent (CTLT) United States $19.736B 59.03
Grifols, S.A (GRFS) Spain $13.600B 15.57
Neurocrine Biosciences (NBIX) United States $10.163B 79.99
Jazz Pharmaceuticals (JAZZ) Ireland $9.304B 15.03
Ionis Pharmaceuticals (IONS) United States $8.533B 83.60
Arrowhead Pharmaceuticals (ARWR) United States $8.441B 0.00
United Therapeutics (UTHR) United States $7.626B 16.24
IPSEN SA ADR (IPSEY) France $7.218B 0.00
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Orion OYJ (ORINY) Finland $6.427B 22.30
Evotec AG (EVTCY) Germany $5.684B 385.28
Sage Therapeutics (SAGE) United States $4.661B 0.00
PTC Therapeutics (PTCT) United States $4.478B 0.00
ChemoCentryx (CCXI) United States $4.213B 0.00
Hypermarcas (HYPMY) Brazil $4.212B 16.63
FibroGen (FGEN) United States $4.006B 0.00
Cronos Group (CRON) Canada $3.946B 0.00
Corcept Therapeutics (CORT) United States $3.340B 32.30
Pacira BioSciences (PCRX) United States $3.208B 69.67
Nektar Therapeutics (NKTR) United States $3.089B 0.00
Revolution Medicines (RVMD) United States $2.852B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.851B 14.56
Xencor (XNCR) United States $2.842B 0.00
Tilray (TLRY) Canada $2.683B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.758B 15.04
USANA Health Sciences (USNA) United States $1.733B 15.25
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.725B 0.00
Translate Bio (TBIO) United States $1.708B 0.00
Heron Therapeutics (HRTX) United States $1.631B 0.00
Endo (ENDP) Ireland $1.626B 2.47
BioCryst Pharmaceuticals (BCRX) United States $1.601B 0.00
ImmunoGen (IMGN) United States $1.546B 0.00
Ocular Therapeutix (OCUL) United States $1.523B 0.00
Trillium Therapeutics (TRIL) Canada $1.494B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.448B 10.06
Indivior (INVVY) United States $1.309B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.182B 0.00
Karyopharm Therapeutics (KPTI) United States $1.110B 0.00
ORGANOGENESIS (ORGO) United States $1.023B 0.00
Zogenix (ZGNX) United States $1.017B 0.00
Radius Health (RDUS) United States $1.008B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.963B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Collegium Pharmaceutical (COLL) United States $0.832B 49.10
Aclaris Therapeutics (ACRS) United States $0.808B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.770B 0.00
VAXART, INC (VXRT) United States $0.756B 0.00
Aerie Pharmaceuticals (AERI) United States $0.706B 0.00
Esperion Therapeutics (ESPR) United States $0.700B 0.00
Acutus Medical (AFIB) United States $0.658B 0.00
Chinook Therapeutics (KDNY) United States $0.640B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.637B 0.00
Ardelyx (ARDX) United States $0.616B 0.00
Harpoon Therapeutics (HARP) United States $0.613B 0.00
Flexion Therapeutics (FLXN) United States $0.590B 0.00
Molecular Templates (MTEM) United States $0.589B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.581B 0.00
Siga Technologies (SIGA) United States $0.557B 15.63
Crinetics Pharmaceuticals (CRNX) United States $0.497B 0.00
Sundial Growers (SNDL) Canada $0.488B 0.00
PROFOUND MEDICL (PROF) Canada $0.465B 0.00
Akebia Therapeutics (AKBA) United States $0.454B 0.00
Altimmune (ALT) United States $0.449B 0.00
Summit Therapeutics (SMMT) United States $0.431B 0.00
CASI Pharmaceuticals (CASI) United States $0.429B 0.00
TherapeuticsMD (TXMD) United States $0.426B 0.00
DURECT (DRRX) United States $0.423B 0.00
Rafael Holdings (RFL) United States $0.396B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.394B 0.00
Jounce Therapeutics (JNCE) United States $0.384B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.371B 9.68
Innate Pharma SA (IPHYF) France $0.371B 0.00
MEI Pharma (MEIP) United States $0.347B 0.00
Concert Pharmaceuticals (CNCE) United States $0.334B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.329B 0.00
Alpine Immune Sciences (ALPN) United States $0.312B 0.00
Nature's Sunshine Products (NATR) United States $0.306B 19.73
KalVista Pharmaceuticals (KALV) United States $0.305B 0.00
Menlo Therapeutics (VYNE) United States $0.299B 0.00
Redhill Biopharma (RDHL) Israel $0.291B 0.00
Lannett Co Inc (LCI) United States $0.281B 7.41
Xeris Pharmaceuticals (XERS) United States $0.275B 0.00
Jaguar Animal Health (JAGX) United States $0.263B 0.00
Otonomy (OTIC) United States $0.250B 0.00
IMV INC (IMV) Canada $0.248B 0.00
CTI BioPharma (CTIC) United States $0.239B 0.00
Oncternal Therapeutics (ONCT) United States $0.226B 0.00
Infinity Pharmaceuticals (INFI) United States $0.223B 0.00
Calithera Biosciences (CALA) United States $0.219B 0.00
OptiNose (OPTN) United States $0.215B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.213B 0.00
IsoRay (ISR) United States $0.210B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.205B 0.00
Novan (NOVN) United States $0.185B 0.00
Aquestive Therapeutics (AQST) United States $0.183B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.176B 0.00
Taiwan Liposome (TLC) Taiwan $0.172B 0.00
Onconova Therapeutics (ONTX) United States $0.161B 0.00
Heat Biologics (HTBX) United States $0.157B 0.00
Champions Oncology (CSBR) United States $0.154B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.153B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.148B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.145B 0.00
ProPhase Labs (PRPH) United States $0.145B 0.00
MediWound (MDWD) Israel $0.144B 0.00
Lipocine (LPCN) United States $0.116B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.108B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.105B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.099B 0.00
ElectroCore (ECOR) United States $0.086B 0.00
Hemispherx BioPharma (AIM) United States $0.085B 0.00
SCYNEXIS (SCYX) United States $0.085B 0.00
Natural Alternatives (NAII) United States $0.083B 161.13
Galmed Pharmaceuticals (GLMD) Israel $0.079B 0.00
Nutriband (NTRB) United States $0.077B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.072B 0.00
Biomerica (BMRA) United States $0.072B 0.00
AgeX Therapeutics (AGE) United States $0.071B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.069B 0.00
India Globalization Capital (IGC) United States $0.066B 0.00
Iterum Therapeutics (ITRM) Ireland $0.064B 0.00
CV Sciences (CVSI) United States $0.061B 0.00
Vical (BBI) United States $0.060B 0.00
Addex Therapeutics (ADXN) Switzerland $0.058B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 24.58
Regulus Therapeutics (RGLS) United States $0.045B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.043B 0.00
PolarityTE (PTE) United States $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.039B 5.74
Neos Therapeutics (NEOS) United States $0.037B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.030B 0.00
Midatech Pharma (MTP) United Kingdom $0.029B 0.00
Flex Pharma (SLRX) United States $0.029B 0.00
Can-Fite Biopharma (CANF) Israel $0.029B 0.00
KemPharm (KMPH) United States $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.021B 0.00
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.019B 31.90
Xenetic Biosciences (XBIO) United States $0.017B 0.00
RXi Pharmaceuticals (PHIO) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Shineco (TYHT) China $0.011B 0.00
JanOne (JAN) United States $0.010B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00